5. Three organs lasting more than 3 d 80%
The American College of Chest Physicians (ACCP) and the
Society of Critical Care
Medicine (SCCM) defined the following terms to describe the
spectrum of systemic
inflammation and sepsis (the International Sepsis Definitions
Conference, 2001):
Systemic inflammatory response syndrome (SIRS) is a clinical
syndrome that results
from activation of the immune system whether due to infection,
trauma, burns, or a
noninfectious inflammatory process. This syndrome includes at
least two of the
following:
(1) Temperature >38°C or <36°C
(2) Heart rate >90 beats/min
(3) Respiratory rate >20 breaths/min or PaCO2 < 32 mm Hg
(4) White blood cell count >12,000 cells/mm3, or <4000
cells/mm3, or >10%
immature (band) forms
Sepsis is a clinical syndrome that results from activation of the
immune system with
a documented infection. The definition of sepsis includes the
above SIRS criteria
plus a culture-proven infection or presumed presence of an
infection.
A recent study has brought into the question the sensitivity of
the current definition,
suggesting that many patients, usually older, do not actually
even have two out of four
SIRS criteria when they are septic. These caveats have not been
7. hypotension with mean
systemic blood pressure lower than 65 mm Hg that is
unresponsive to crystalloid fluid
challenge of 20 to 40 cc/kg. Septic shock leads to acute
circulatory collapse.
PATHOPHYSIOLOGY
Sepsis is as an uncontrolled inflammatory response to an
infection in which a
dysregulated host immune response leads to multiorgan
involvement not limited to the
source infected organ. Microbial antigens such as
lipopolysaccharides (LPS) from Gram-
negative bacteria bind to Toll-like receptors on inflammatory
cells, thereby causing a
complex immune reaction involving T-cells, macrophages,
neutrophil, endothelial cells, and
dendritic cells. Cytokines (such as IL-1, IL-6, IL-8), growth
factors (such as TNFa), high-
mobility group box-1 (HMGB-1), arachidonic acid metabolites,
and nitric oxide and host
genetics likely determine the nature of the response. The
complement cascade,
coagulation cascades, platelets, and leukocytes interact at the
vascular endothelium level
resulting in microvascular injury, thrombosis, and loss of
endothelial integrity, which
altogether results in tissue ischemia. This diffuse endothelial
disruption is responsible for
the various organ dysfunctions and global tissue hypoxia that
accompany severe sepsis
and septic shock. Multiple mechanisms including decreased
preload, vasoregulatory
dysfunction, myocardial depression, and impaired tissue
extraction due to
microcirculatory dysfunction or mitochondrial dysfunction
8. (cytopathic hypoxia) cause
global tissue hypoxia. Some noninfectious processes (eg,
pancreatitis) may also lead to a
dysregulated host immune response and multiorgan dysfunctio n,
and these conditions are
categorized using the term SIRS. These patients appear septic
without a clear infectious
source.
DIFFERENTIAL DIAGNOSIS
The differential diagnosis for conditions that cause sepsis
includes conditions that
present with high-output nonshock states. Common disorders
that meet SIRS criteria
include nonmassive pulmonary embolus, alcohol withdrawal,
even COPD exacerbations.
Thyrotoxicosis, aortic regurgitation, arteriosclerosis, and
cirrhosis may mimic sepsis with
high cardiac output state and wide pulse pressure without shock.
Conditions that belong to the category of vasodilatory or high
cardiac output shock
include anaphylaxis, adrenal insufficiency, and neurogenic
shock in addition to septic
shock. The other causes of shock all fall into a category of low-
output states, including
cardiogenic shock, hypovolemic shock, and obstructive shock
(Table 141-3).
TABLE 141-3 Differential Diagnosis of Shock
Vasodilatory shock Sepsis
Anaphylaxis
Adrenal insufficiency
Neurogenic
10. and elevated cardiac
output, and coagulopathy. Late manifestations include acute
lung injury (ALI), ARDS,
acute renal failure, hepatic dysfunction, and refractory shock.
Sepsis may be related to a systemic inflammatory response to
any infectious source.
Less than 50% of septic patients will have positive blood
cultures, and 20% to 30% of
patients will have no microbial cause identified from any
source. Aggressive clinical
evaluation includes a detailed history and review of systems. A
complete physical
examination can assess for sometimes inconspicuous and missed
infection sources,
including skin and soft tissue, central nervous system,
gastrointestinal tract, and
indwelling devices.
It is critical to stabilize the patient and identify the cause of the
ongoing immunologic
response. Obtaining cultures for blood, urine, and other fluids
early, prior to administration
of antibiotics, should be a high priority and helps preserve the
integrity of results, but the
evaluation should not be at the expense of administering
antibiotics expediently.
Identification of the underlying source remains paramount, and
lack of source
identification and control may render choice of antibiotics
meaningless. The most
common sites of infection in sepsis are the urinary and
respiratory tracts, but any organ
system may be involved. Urinary sources include cystitis,
pyelonephritis, and perinephric
abscess. Patients with kidney stones may develop Gram-
12. in patients with pleural
effusions. When plain films, blood cultures, and fluid cultures
do not yield a likely
infectious culprit, advanced imaging with chest and abdominal
computed tomography
may identify pulmonary infiltrates, intra-abdominal abscesses,
and obstructing renal
stones. Biliary pathology may be better imaged with ultrasound.
In hemodynamically
stable patients, magnetic resonance imaging (MRI), or
endoscopic retrograde
pancreatography (ERCP) may be indicated. Many patients
undergo echocardiography to
assess cardiac function and to identify the presence of
vegetations.
TRIAGE AND HOSPITAL ADMISSION
All patients with a presentation of severe sepsis or septic shock
should be admitted to or
transferred to a monitored setting that is capable of continuous
vital sign monitoring with
the ability to measure central venous pressure (CVP) and central
venous oxygen
saturations (ScvO2).
PRACTICE POINT
Recent data suggest that most septic shock patients may be
managed without the use
of CVP or ScvO2 monitoring; however the values may still be
used to assess response
to therapy in selected patients with undifferentiated or mixed
shock and in patients
with underlying organ dysfunction such as chronic kidney
disease and cognitive
impairment.
15. especially when the presumptive source of infection is not
obvious, multiple antibiotic
agents should be initiated to offer broad antimicrobial coverage.
Such broad coverage
should then be re-evaluated daily to optimize dosing and
minimize drug interactions and
the development of resistance. Choice of antibiotic depends
upon penetration into the
suspected infection site, local resistance patterns, efficacy
against the most likely
organisms, prior exposure to specific antibiotics, and risks of
side effects. Therapeutic
drainage of an infected space is critical to diagnose the source
of infection, guide the
choice of antibiotic therapy, and facilitate recovery. In patients
with devices, clinicians may
need to evaluate and consider early and rapid removal of
potentially or known infected
invasive devices including central venous catheters (CVCs),
peripherally inserted central
venous catheters (PICCs), urinary catheters, and other
implanted hardware.
Recent evidence suggests that mortality increases with delay of
antibiotics more than
1 hour after identification and management of severe sepsis or
septic shock. Patients at
risk of fungal infections (ie, recent abdominal surgery, total
parenteral nutrition (TPN)
administration, chronic steroid use) may benefit from empiric
antifungal agents in
addition to the antimicrobial regimen.
More data is needed before recommending use of procalcitonin
levels in septic
patients. While there is reasonable evidence that procalcitonin
16. may be useful in the
management of community acquired pneumonia and COPD
exacerbations, the evidence
for its use in decisions to discontinue antibiotics in septic
patients is less robust. Studies
comparing a calcitonin-guided algorithm with standard
management show no difference
in the amount of time spent on antibiotics.
INTRAVENOUS FLUIDS
Volume resuscitation should begin simultaneously with empiric
antibiotic therapy in
patients suspected of having sepsis. In the vasodilatory state
low blood pressures with
decreased venous return lead to an underfilled, but
hyperdynamic heart. Rivers and
colleagues showed that early goal-directed therapy (EGDT),
initiated in the emergency
department, improved mortality in patients with severe sepsis
and septic shock.
For routine use in sepsis, crystalloid fluid should be used first
due to evidence of
benefit, markedly lower expense, and demonstrated safety
(lacking the inherent risks of
blood product administration with albumin). The Saline Versus
Albumin Fluid Evaluation
(SAFE) study evaluated nearly 7,000 critically ill patients, 18%
of whom had severe sepsis.
Patients were randomly assigned to receive 4% albumin versus
normal saline, and
investigators reported no differences in mortality at 28 days.
Additionally, there were no
significant differences seen in the sepsis subgroup. Despite a
theoretic benefit to using
18. Early goal-directed therapy includes early aggressive volume
resuscitation in the first 6
hours of care, and other measures over the first hours and days
of care (see Figure 141-1).
Close monitoring of central venous pressure (CVP) is
accomplished with a central venous
catheter placed in the internal jugular or subclavian vein.
Central venous pressure and
ScvO2 monitoring allows adjustment of or addition of
interventions based on the
parameters measured within the individual patient to achieve
the goal of ScvO2 at 70%, if
the patient remains hypotensive (mean arterial pressure [MAP]
< 65 mm Hg) after a
reasonable fluid challenge with crystalloid (approximately 20-
40 cc/kg) to optimize filling
pressures.
The EGDT algorithm, whose utility has come into question with
three recent trials, uses
a CVP goal of 8 to 12 cm H2O, which is a reasonable estimate
goal. However, that goal
should not be applied blindly to all patients without knowledge
of coexisting conditions
including pulmonary arterial hypertension, dilated
cardiomyopathy, and old right
ventricular infarction. Clinicians may follow the trend of the
CVP and correlate it with the
ScvO2, patient hemodynamics, and evidence of organ perfusion
including mental status
and urine output. Ample data suggest that the CVP serves as a
poor predictor of volume
responsiveness, and multiple factors are necessary to determine
the need for continued
volume resuscitation including passive leg raising and pulse
pressure variation. Passive
19. leg raise is a technique in which a spontaneously breathing
patient is placed with the legs
elevated, essentially transferring approximately 300 cc of
intravascular fluid into the
thorax, followed by measurement of cardiac output. This
technique avoids the
administration of exogenous fluid. The measurement of ScvO2
carries valuable
information and weight, offering the clinician an assessment of
cardiac function and
oxygen delivery balanced against oxygen consumption.
Despite strong evidence from the original Rivers et al. EGDT
trial more than a decade
ago, recent publications of the PROCESS (Protocolized Care for
Early Septic Shock) trial,
the ARISE (Australasian Resuscitation in Early Septic Shock)
trial, and the PRoMISe
(Protocolized Management in Septic Shock) trial have
challenged the utility of the Rivers
EGDT algorithm. The three trials showed that with early
recognition of septic shock in the
emergency department, management according to the Rivers’
EGDT algorithm, including
placement of central lines and measurement of CVP and ScvO2,
did not improve any
outcome measures when compared to standard management. The
results of these three
large, multicenter, randomized control trials have seriously
challenged what had become
axiomatic since the publication of Rivers original EGDT trial. A
change in management,
however, may not be immediate as more than 50% of the
patients in the EGDT and non-
21. (cardiogenic,
hypovolemic, obstructive).
In sepsis, as in other vasodilatory or high cardiac output states,
low oxygen extraction
—possibly due to mitochondrial dysfunction—leads to higher
values of ScvO2. Often,
these higher values of ScvO2 are not apparent until the patient
has been adequately
resuscitated with intravascular volume expansion. The mean
ScvO2 in the Rivers study
was 55%, which is lower than values seen in other sepsis trials.
Early goal-directed therapy (EGDT) studies initially suggested
that clinicians should
augment therapeutic interventions when ScvO2 is less than 70%
in patients with severe
sepsis or septic shock. Three recent studies have shown that
outcomes are no worse
when ScvO2 is not used to guide management. More recent
studies suggest that
lactate clearance of at least 10% at a minimum of 2 hours after
beginning volume
resuscitation is a valid way to assess the efficacy of intravenous
fluid administration.
For EGDT the order of therapy augmentation included: volume
expansion (to achieve
CVP 8-12 mm Hg) → pressor agents (to achieve MAP ≥ 65 mm
Hg) → transfusion of
packed RBCs (to achieve an ScvO2 ≥ 70%) → inotropic agents
(to achieve an ScvO2 ≥
70%). This sequence has been challenged by the same three
studies comparing EGDT
versus standard treatment. A less codified algorithm might
include 20-30 cc/kg fluid
administration, pressor administration for patients who remain
hypotensive with signs
of hypoperfusion, further evaluation of the need for additional
23. meeting EGDT criteria. The
2013 Surviving Sepsis Guidelines were revised for red cell
transfusions due to the
controversy and conflicting data regarding the benefits and risks
of red blood cell
transfusions. Current recommendations employ a transfusion
threshold of 7 gm/dL once
tissue hypoperfusion has resolved, except in the setting of
active cardiac ischemia, blood
loss, severe hypoxemia, and ischemic heart disease. The target
goal recommendation is 7
gm/dl to 9 mg/dL, and transfusion for hemoglobin threshold less
than 7 g/dL has been
shown to have equivalent outcomes for mortality and other
relevant outcomes as
transfusion for a hemoglobin threshold less than 9 g/dL in
patients with septic shock
based on the 2014 TRISS trial.
VASOACTIVE MEDICATIONS
An important aspect of sepsis management includes vasoactive
medications.
Vasopressors are often required to maintain mean arterial blood
pressures (MAP) above a
target value and the choice of agent depends on the physiologic
need (Table 141-4). The
EGDT protocol recommends vasopressor agents to maintain
MAP ≥ 65 mm Hg. There is
no firm evidence favoring one vasopressor agent over another,
but norepinephrine likely
has the greatest vasoconstrictor potency along with some
inotropic effect. The most
recent Surviving Sepsis Guidelines recommend epinephrine as
the second line
vasopressor of choice after norepinephrine based on several
randomized studies
25. Yes Yes (but less
than
dopamine)
Yes • First line for many
patients with severe
sepsis or septic shock
• Significant
vasoconstriction with
inotropy which is
helpful for patients
with poor left
ventricular reserve or
sepsis-related
cardiomyopathy
Dopamine 1-5
mcg/kg/min,
increased renal blood
flow; 5-10
mcg/kg/min,
increased
chronotropy/inotropy;
>10 mcg/kg/min,
predominant
vasoconstriction,
increased blood
pressure
Yes Yes Yes • Not a first line
vasopressor for severe
sepsis or septic shock.
May be useful for
severe bradycardia
26. and mild hypotension
• Randomized
comparison to
norepinephrine
showed no significant
differences in
mortality, but
increased arrhythmias
with dopamine and
increased mortality in
cardiogenic shock
• More tachycardia than
with norepinephrine
• More potent inotrope
than norepinephrine
• Differing effects at
escalating doses with
vasoconstriction at
highest dose
• Available in premixed
or preprepared bags
and therefore can be
initiated quickly during
emergent need
Epinephrine Yes Yes Yes • Second line
vasopressor after
norepinephrine in
severe sepsis, septic
shock. Similar to
28. 350 words per answer, Minimum 1 Academic Source for each
answer
1. Typical users of financial statements include internal users
such as managers and external users such as creditors, investors,
regulatory agencies. Which of these users would find more
helpful information on the balance sheet and why? And which
of these users would find more helpful information on the
income statement and why?
2. Discuss the opinion that ‘accounting is the language of
business.’